{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:10:04Z","timestamp":1746097804252,"version":"3.40.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.eplepsyres.2025.107551","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T11:45:22Z","timestamp":1743767122000},"page":"107551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enteral topiramate treatment in refractory status epilepticus"],"prefix":"10.1016","volume":"213","author":[{"given":"Selda","family":"Keskin-G\u00fcler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6mer","family":"Karada\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2048-4930","authenticated-orcid":false,"given":"Murat Mert","family":"Atmaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibel \u00dcst\u00fcn","family":"\u00d6zek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulshan","family":"Yunisova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eser","family":"Bulu\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulya","family":"Eren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melek Colak","family":"Atmaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4330-7558","authenticated-orcid":false,"given":"Aylin","family":"Reyhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candan","family":"G\u00fcrses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2025.107551_bib1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00381-011-1432-y","article-title":"Treatment of pediatric refractory status epilepticus with topiramate","volume":"27","author":"Aky\u0131ld\u0131z","year":"2011","journal-title":"Child's Nerv. Syst."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.seizure.2014.09.009","article-title":"Treatment of refractory generalized convulsive status epilepticus with enteral topiramate in resource limited settings","volume":"24","author":"Asadi-Pooya","year":"2015","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107551_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.yebeh.2003.07.016","article-title":"Topiramate and status epilepticus: report of three cases","volume":"4","author":"Bensalem","year":"2003","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/00003088-200443120-00001","article-title":"Pharmacokinetic interactions of topiramate","volume":"43","author":"Bialer","year":"2004","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107551_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s12028-022-01489-0","article-title":"Impact of seizures and status epilepticus on outcome in patients with aneurysmal subarachnoid hemorrhage","volume":"36","author":"B\u00f6gli","year":"2022","journal-title":"Neurocritical Care"},{"key":"10.1016\/j.eplepsyres.2025.107551_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40265-016-0672-2","article-title":"Topiramate in the treatment of generalized convulsive status epilepticus in adults: a systematic review with individual patient data analysis","volume":"77","author":"Brigo","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.eplepsyres.2025.107551_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocritical Care"},{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107551_bib8","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/epi.12165","article-title":"Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate","volume":"54","author":"Clark","year":"2013","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107551_bib9","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/epi.12165","article-title":"Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate","volume":"54","author":"Clark","year":"2013","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107551_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/epi.12134","article-title":"Intravenous topiramate: comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers","volume":"54","author":"Clark","year":"2013","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.eplepsyres.2025.107551_bib11","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/epi.16382","article-title":"Treatment of refractory and superrefractory status epilepticus with topiramate: a cohort study of 106 patients and a review of the literature","volume":"60","author":"Fechner","year":"2019","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107551_bib12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107551_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107551_bib14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2003","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107551_bib15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2025.107551_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/11633090-000000000-00000","article-title":"Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study","volume":"26","author":"Hottinger","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2025.107551_bib17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.seizure.2015.03.011","article-title":"Aetiology and outcome of generalized convulsive status epilepticus in elderly","volume":"29","author":"Jayalakshmi","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2025.107551_bib18","first-page":"1","article-title":"Prediction of mortality and functional outcome from status epilepticus and independent external validation of STESS and EMSE scores","volume":"20","author":"Kang","year":"2015","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107551_bib19","first-page":"232","article-title":"Epilepsy Comorbidities","volume":"31","author":"Keezer","year":"2025","journal-title":"CONTINUUM: Lifelong Learn. Neurol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107551_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.14581\/jer.11010","article-title":"Effectiveness of topiramate in medically complicated patients with status epilepticus or acute refractory seizures","volume":"1","author":"Kim","year":"2011","journal-title":"J. Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.yebeh.2015.04.066","article-title":"Predicting outcome of status epilepticus","volume":"49","author":"Leitinger","year":"2015","journal-title":"Epilepsy Behav."},{"issue":"10","key":"10.1016\/j.eplepsyres.2025.107551_bib22","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1474-4422(16)30137-5","article-title":"Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: a retrospective study","volume":"15","author":"Leitinger","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.109032","article-title":"The potential of intravenous topiramate for the treatment of status epilepticus","volume":"138","author":"L\u00f6scher","year":"2023","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib24","doi-asserted-by":"crossref","first-page":"1360949","DOI":"10.3389\/fnmol.2024.1360949","article-title":"Risk factors and a predictive model for the occurrence of adverse outcomes in patients with new-onset refractory status epilepsy","volume":"17","author":"Luo","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eplepsyres.2017.07.006","article-title":"Status epilepticus-related etiology, incidence and mortality: a meta-analysis","volume":"136","author":"Lv","year":"2017","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.seizure.2016.03.003","article-title":"Assessing the value of topiramate in refractory status epilepticus","volume":"38","author":"Mad\u017ear","year":"2016","journal-title":"Seizure"},{"issue":"11","key":"10.1016\/j.eplepsyres.2025.107551_bib27","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1093\/brain\/awab188","article-title":"Survival of brain tumour patients with epilepsy","volume":"144","author":"Mastall","year":"2021","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107551_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107551_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"Meierkord","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1528-1167.2006.00870.x","article-title":"Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy","volume":"47","author":"Minicucci","year":"2006","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107551_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1528-1167.2009.02323.x","article-title":"Refractory status epilepticus: a prospective observational study","volume":"51","author":"Novy","year":"2010","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107551_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1535759721999670","article-title":"Treatment of super-refractory status epilepticus: a review","volume":"21","author":"Ochoa","year":"2021","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/801834","article-title":"Underestimated rate of status epilepticus according to the traditional definition of status epilepticus","volume":"2015","author":"Ong","year":"2015","journal-title":"Sci. World J."},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107551_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/NRL.0000000000000281","article-title":"Treatment of status epilepticus: what are the guidelines and are we following them?","volume":"25","author":"Parsons","year":"2020","journal-title":"Neurologist"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107551_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1468-1331.2002.00304.x","article-title":"Topiramate in drug-resistant complex partial status epilepticus","volume":"9","author":"Reuber","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1528-1167.2007.01359.x","article-title":"The epidemiology of convulsive and nonconvulsive status epilepticus","volume":"48","author":"Rosenow","year":"2007","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107551_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ncl.2024.07.002","article-title":"Refractory and super-refractory status epilepticus: therapeutic options and prognosis","volume":"43","author":"Rossetti","year":"2025","journal-title":"Neurol. Clin."},{"issue":"11","key":"10.1016\/j.eplepsyres.2025.107551_bib38","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/archneur.62.11.1698","article-title":"Refractory status epilepticus: effect of treatment aggressiveness on prognosis","volume":"62","author":"Rossetti","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib39","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","article-title":"Status Epilepticus Severity Score (STESS) A tool to orient early treatment strategy","volume":"255","author":"Rossetti","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00415-012-6644-x","article-title":"Treatment deviating from guidelines does not influence status epilepticus prognosis","volume":"260","author":"Rossetti","year":"2013","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107551_bib41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107551_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1527-3458.2008.00041.x","article-title":"Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate","volume":"14","author":"Shank","year":"2008","journal-title":"CNS Neurosci. Ther."},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107551_bib43","first-page":"317","article-title":"Enteral topiramate in a pediatric patient with refractory status epilepticus: a case report and review of the literature","volume":"19","author":"Shelton","year":"2014","journal-title":"J. Pediatr. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.eplepsyres.2025.107551_bib44","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.3390\/ijms22052264","article-title":"Anticonvulsant effects of topiramate and lacosamide on pilocarpine-induced status epilepticus in rats: a role of reactive oxygen species and inflammation","volume":"22","author":"Shishmanova-Doseva","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.eplepsyres.2025.107551_bib45","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/brain\/aws091","article-title":"The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy","volume":"135","author":"Shorvon","year":"2012","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.eplepsyres.2025.107551_bib46","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1528-1167.2008.01706_3.x","article-title":"The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus","volume":"49","author":"Shorvon","year":"2008","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107551_bib47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jamaneurol.2023.0611","article-title":"Association of mortality and risk of epilepsy with type of acute symptomatic seizure after ischemic stroke and an updated prognostic model","volume":"80","author":"Sinka","year":"2023","journal-title":"JAMA Neurol."},{"issue":"2-3","key":"10.1016\/j.eplepsyres.2025.107551_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.eplepsyres.2011.09.017","article-title":"The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center","volume":"98","author":"Synowiec","year":"2012","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107551_bib49","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1212\/01.WNL.0000042783.86439.27","article-title":"The use of topiramate in refractory status epilepticus","volume":"60","author":"Towne","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2025.107551_bib50","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","article-title":"Pharmacotherapy for status epilepticus","volume":"75","author":"Trinka","year":"2015","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.eplepsyres.2025.107551_bib51","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107551_bib52","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1517\/14656566.2016.1127354","article-title":"Pharmacologic treatment of status epilepticus","volume":"17","author":"Trinka","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.eplepsyres.2025.107551_bib53","doi-asserted-by":"crossref","first-page":"1081757","DOI":"10.3389\/fepid.2023.1081757","article-title":"Mortality, and life expectancy in Epilepsy and Status epilepticus-current trends and future aspects","volume":"3","author":"Trinka","year":"2023","journal-title":"Front. Epidemiol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092012112500052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092012112500052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T10:35:23Z","timestamp":1746095723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092012112500052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":53,"alternative-id":["S092012112500052X"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107551","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enteral topiramate treatment in refractory status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107551"}}